Shilanski & Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,815
Closed -$1.51M 109
2022
Q1
$1.51M Buy
6,815
+15
+0.2% +$3.17K 0.63% 43
2021
Q4
$1.59M Sell
6,800
-56
-0.8% -$13.9K 0.68% 47
2021
Q3
$1.5M Buy
6,856
+227
+3% +$48.5K 0.7% 46
2021
Q2
$1.12M Buy
6,629
+443
+7% +$71.5K 0.53% 56
2021
Q1
$905K Buy
6,186
+49
+0.8% +$7.86K 0.48% 60
2020
Q4
$905K Buy
+6,137
New +$729K 0.55% 55

Other funds holding ALB

Shilanski & Associates's ALB Position: Q2 2022 in Review

Shilanski & Associates sold out of Albemarle (ALB) in Q2 2022, closing a stake of 6,815 shares — an estimated $1.51M sold.

Shilanski & Associates first reported a position in ALB in Q4 2020 and held it in 6 quarters. The position peaked at $1.59M in Q4 2021. 885 funds tracked by Wall St. Rank hold ALB as of Q2 2022.

  • Shilanski & Associates reported no remaining Albemarle position as of Q2 2022 after selling out during the quarter.
  • Shilanski & Associates sold 6,815 Albemarle shares in Q2 2022, an estimated $1.51M.
  • Shilanski & Associates first reported a position in Albemarle in Q4 2020 and held it in 6 quarters.
  • Shilanski & Associates's Albemarle position peaked at $1.59M in Q4 2021.
  • 885 funds tracked by Wall St. Rank held Albemarle as of Q2 2022.

Based on Shilanski & Associates's 13F filing for Q2 2022, filed 2 Aug 2022.